Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BioLum Sciences logo — Transforming Precision Drug Discovery and Early Detection of...

BioLum Sciences

Transforming Precision Drug Discovery and Early Detection of Disease

Founded 2015 United States Dallas, United States 5 employees Grant Total: $1.05M Biotechnology, Digital Health +2

General Information

Company Name BioLum Sciences
Founded Year 2015
Location United States Dallas, United States +1
Employees 5
Industries Biotechnology, Digital Health, Health Care +1
Funding Stage Grant
Social

Get notified when BioLum Sciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BioLum Sciences

BioLum Sciences is a biotechnology startup based in the United States that is focused on transforming precision drug discovery and early detection of disease. Leveraging biomarker analysis with an integrated approach, BioLum is providing highly-sensitive, selective assays and lab services to facilitate more efficient therapeutic R&D. The company's assays, with a primary focus on reactive oxygen, nitrogen, and sulfur species (RONSS), have surpassed gold standards and offer improved chemiluminescence, which eliminates background autofluorescence, ensuring superior accuracy and precision with broad specimen compatibility. Notably, BioLum collaborates with pharmaceutical companies and researchers in preclinical discovery and development. Its services range from biomarker analysis, compound library screening, and efficacy testing to early target identification and validation. The company's focus on reactive species, which are implicated in various diseases such as inflammation, cardiovascular, respiratory, neurological, and immune-related conditions, highlights the broad impact of its technology. In terms of financial backing, BioLum Sciences recently secured a $251.94K grant investment on 22 December 2021 from the National Institute of General Medical Science. This funding serves to support the company's continued advancement in precision medicine and early disease detection. With its innovative approach and industry relevance, BioLum Sciences presents a promising investment opportunity in the biotechnology and healthcare sectors.

Taxonomy: Precision Medicine, Biomarker Analysis, Drug Discovery, Early Disease Detection, Oxidative Stress, Nitric Oxide, Chemiluminescence, Assay Development, Pulmonary Arterial Hypertension, Respiratory Diseases, Cardiovascular Health, Remote Patient Monitoring, Chronic Diseases

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 22 Dec 2021
Grant •••••• 1
Investor
01 May 2020
Corporate Round •••••• 1
Investor
10 Oct 2019
Pre Seed Round •••••• - 07 Sep 2017

BioLum Sciences Alternatives & Competitors

BioLum Sciences vs
Pharmatest Services
Pharmatest Services Finland

Pharmatest is a CRO that offers preclinical efficacy services in therapeutic areas of oncology and s...

Private Equity
17 employees
Biotechnology, Pharmaceutical
BioLum Sciences vs
Truly Labs
Truly Labs Sweden

Your Preclinical Lab Partner

Seed
27 employees
Biopharma
BioLum Sciences vs
Nordic Bioscience
Nordic Bioscience Denmark

Improving preclinical and clinical trial success rates with world-leading biomarkers & specialized l...

Private Equity
224 employees
Biotechnology, Health Care

FAQ About BioLum Sciences

Transforming Precision Drug Discovery and Early Detection of Disease
BioLum Sciences was founded in 2015.
BioLum Sciences is headquartered in Dallas, United States.
BioLum Sciences operates in the following industries: Biotechnology, Digital Health, Health Care, Medical Devices.
BioLum Sciences has approximately 5 employees.
BioLum Sciences has completed 4 funding rounds, raising a total of $1.05M. The latest funding stage is Grant.
Top alternatives and competitors to BioLum Sciences include Pharmatest Services, Truly Labs, Nordic Bioscience, BioDot, Inc, ARCHIMEDlife Medical Laboratories. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioLum Sciences and Pharmatest Services are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BioLum Sciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy